Additional information

Cell signalling is used to study pathways of cells in drug discovery and therapeutic development. It is a complex process of communication which rules the basic activities of cells and coordinates cell actions to decide drug resistance patterns in cancerous cells. Global cell signalling market value is projected to be $2.53 Billion in 2017 and is expected to generate revenue of around $4.08 Billion by the end of 2024, growing at a CAGR of around 6.8% between 2017 and 2024. The growth of end-use industries and rising incidence of chronic diseases are the factors enhancing the growth of the market. Complexities related to antibody and reagent development and the high cost of cell signalling systems are the factors which hamper the market growth. Emerging markets and emergence of microfluidics in cell biology research are the opportunities for cell signalling market.

Analysis and conclusions on the future cell signalling market outlook.

Top-down and bottom-up approaches are used to validate the cell signalling market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The cell signalling market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the cell signalling market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Cell signalling market segmentation is as follows:

By Signalling Type

Endocrine signalling

Paracrine signalling

Autocrine signalling

Juxtacrine signalling

Other signalling types

By Product

Consumables

Instruments

By Technology

Microscopy

Flow Cytometry

Mass spectrometry

Western blotting

Elisa

Immunohistochemistry

Other technologies

By Pathway

AKT signalling pathway

AMPK signalling pathway

ErbB/HER signalling pathway

Hedgehog signalling pathway

JAK/STAT signalling pathway

Notch signalling pathway

NF-KB signalling pathway

Other signalling pathways

By Application

Research applications

Medical applications

Geographical Analysis:

Cell signalling market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the cell signalling market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Cell signalling Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant cell signaling market players, such as

Beckman Coulter Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories Inc.

Cell Signaling Technology Inc.

The Merck Group.

Along with these companies, many other companies are considered in the report while analysing the global cell signalling competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1. INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

4.1. Market Drivers

4.1.1. The growth of end-use industries

4.1.2. Rising incidence of chronic diseases

4.1.3. Technological advancements in cell-based research instruments

4.1.4. Availability of funding for cell-based research

4.2. Market Restraints & Challenges

4.2.1. Complexities related to antibody and reagent development

4.2.2. The high cost of cell signalling systems

4.3. Market Opportunities

4.3.1. The emergence of microfluidics in cell biology research

4.3.2. Emerging markets

CHAPTER 5. GLOBAL CELL SIGNALING MARKET – BY PRODUCT

5.1. Introduction

5.2. Consumables

5.2.1. Antibodies

5.2.2. Reagents

5.2.3. Assay Kits

5.2.4. Other Consumables

5.3. Instruments

CHAPTER 6. GLOBAL CELL SIGNALING MARKET – BY TECHNOLOGY

6.1. Introduction

6.2. Western blotting

6.3. Elisa

6.4. Immunohistochemistry

6.5. Flow cytometry

6.6. Microscopy

6.7. Mass spectrometry

6.8. Other technologies

CHAPTER 7. GLOBAL CELL SIGNALING MARKET – BY SIGNALING TYPE

7.1. Introduction

7.2. Juxtacrine signalling

7.3. Autocrine signalling

7.4. Paracrine signalling

7.5. Endocrine signalling

7.6. Other signalling types

CHAPTER 8. GLOBAL CELL SIGNALING MARKET – BY PATHWAY

8.1. Introduction

8.2. AMPK signalling pathway

8.3. ErbB/HER signalling pathway

8.4. Hedgehog signalling pathway

8.5. JAK/STAT signalling pathway

8.6. Notch signalling pathway

8.7. NF-KB signalling pathway

8.8. AKT signalling pathway

8.9. Other signalling pathways

GLOBAL 9. GLOBAL CELL SIGNALING MARKET – BY APPLICATION

9.1. Introduction

9.2. Medical applications

9.3. Research applications

9.3.1. Cancer research

9.3.2. Immunology research

9.3.3. Stem cells research

9.3.4. Other research applications

9.4. Medical applications

CHAPTER 10. GLOBAL CELL SIGNALING MARKET – BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. U.S.

10.2.2. Canada

10.2.3. Mexico

10.2.4. Costa Rica

10.3. South America

10.3.1. Brazil

10.3.2. Argentina

10.3.3. Chile

10.3.4. Columbia

10.3.5. Others

10.4. Europe

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Russia

10.4.7. Netherlands

10.4.8. Switzerland

10.4.9. Poland

10.4.10. Others

10.5. APAC

10.5.1. China

10.5.2. Japan

10.5.3. India

10.5.4. South Korea

10.5.5. Australia & New Zealand

10.5.6. Malaysia

10.5.7. Singapore

10.5.8. Others

10.6. Middle East & Africa

10.6.1. UAE

10.6.2. Saudi Arabia

10.6.3. Iran

10.6.4. Iraq

10.6.5. Qatar

10.6.6. South Africa

10.6.7. Algeria

10.6.8. Morocco

10.6.9. Nigeria

10.6.10. Egypt

10.6.11. Others

CHAPTER 11. GLOBAL CELL SIGNALING MARKET – COMPANY PROFILES

11.1. Beckman Coulter Inc.

11.2. Becton, Dickinson and Company

11.3. Bio-Rad Laboratories Inc.

11.4. Bio-Techne Corporation.

11.5. Cell Signaling Technology Inc.

11.6. The Merck Group

11.7. PerkinElmer Inc.

11.8. Promega Corporation.

11.9. Ge Healthcare.

11.10. Qiagen N.V.

11.11. Thermo Fisher Scientific Inc.

11.12. Luminex Corporation

11.13. Danaher Corporation.

11.14. Euro Clone S.p.A.

11.15. Irvine Scientific Sales Company, Inc.

CHAPTER 12. GLOBAL CELL SIGNALING MARKET – COMPETITIVE

LANDSCAPE

12.1. Market Share Analysis

12.2. Strategies adopted by top companies

12.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 13. MARKET INSIGHTS

13.1. Industry Experts Insights

13.2. Analysts Opinions

13.3. Investment Opportunities

CHAPTER 14. APPENDIX

14.1. List of Tables

14.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Cell signalling is used to study pathways of cells in drug discovery and therapeutic development. It is a complex process of communication which rules the basic activities of cells and coordinates cell actions to decide drug resistance patterns in cancerous cells. Global cell signalling market value is projected to be $2.53 Billion in 2017 and is expected to generate revenue of around $4.08 Billion by the end of 2024, growing at a CAGR of around 6.8% between 2017 and 2024. The growth of end-use industries and rising incidence of chronic diseases are the factors enhancing the growth of the market. Complexities related to antibody and reagent development and the high cost of cell signalling systems are the factors which hamper the market growth. Emerging markets and emergence of microfluidics in cell biology research are the opportunities for cell signalling market.

Analysis and conclusions on the future cell signalling market outlook.

Top-down and bottom-up approaches are used to validate the cell signalling market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The cell signalling market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the cell signalling market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Cell signalling market segmentation is as follows:

By Signalling Type

Endocrine signalling

Paracrine signalling

Autocrine signalling

Juxtacrine signalling

Other signalling types

By Product

Consumables

Instruments

By Technology

Microscopy

Flow Cytometry

Mass spectrometry

Western blotting

Elisa

Immunohistochemistry

Other technologies

By Pathway

AKT signalling pathway

AMPK signalling pathway

ErbB/HER signalling pathway

Hedgehog signalling pathway

JAK/STAT signalling pathway

Notch signalling pathway

NF-KB signalling pathway

Other signalling pathways

By Application

Research applications

Medical applications

Geographical Analysis:

Cell signalling market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the cell signalling market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Cell signalling Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant cell signaling market players, such as

Beckman Coulter Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories Inc.

Cell Signaling Technology Inc.

The Merck Group.

Along with these companies, many other companies are considered in the report while analysing the global cell signalling competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1. INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3. MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4. MARKET DYNAMICS

4.1. Market Drivers

4.1.1. The growth of end-use industries

4.1.2. Rising incidence of chronic diseases

4.1.3. Technological advancements in cell-based research instruments

4.1.4. Availability of funding for cell-based research

4.2. Market Restraints & Challenges

4.2.1. Complexities related to antibody and reagent development

4.2.2. The high cost of cell signalling systems

4.3. Market Opportunities

4.3.1. The emergence of microfluidics in cell biology research

4.3.2. Emerging markets

CHAPTER 5. GLOBAL CELL SIGNALING MARKET – BY PRODUCT

5.1. Introduction

5.2. Consumables

5.2.1. Antibodies

5.2.2. Reagents

5.2.3. Assay Kits

5.2.4. Other Consumables

5.3. Instruments

CHAPTER 6. GLOBAL CELL SIGNALING MARKET – BY TECHNOLOGY

6.1. Introduction

6.2. Western blotting

6.3. Elisa

6.4. Immunohistochemistry

6.5. Flow cytometry

6.6. Microscopy

6.7. Mass spectrometry

6.8. Other technologies

CHAPTER 7. GLOBAL CELL SIGNALING MARKET – BY SIGNALING TYPE

7.1. Introduction

7.2. Juxtacrine signalling

7.3. Autocrine signalling

7.4. Paracrine signalling

7.5. Endocrine signalling

7.6. Other signalling types

CHAPTER 8. GLOBAL CELL SIGNALING MARKET – BY PATHWAY

8.1. Introduction

8.2. AMPK signalling pathway

8.3. ErbB/HER signalling pathway

8.4. Hedgehog signalling pathway

8.5. JAK/STAT signalling pathway

8.6. Notch signalling pathway

8.7. NF-KB signalling pathway

8.8. AKT signalling pathway

8.9. Other signalling pathways

GLOBAL 9. GLOBAL CELL SIGNALING MARKET – BY APPLICATION

9.1. Introduction

9.2. Medical applications

9.3. Research applications

9.3.1. Cancer research

9.3.2. Immunology research

9.3.3. Stem cells research

9.3.4. Other research applications

9.4. Medical applications

CHAPTER 10. GLOBAL CELL SIGNALING MARKET – BY GEOGRAPHY

10.1. Introduction

10.2. North America

10.2.1. U.S.

10.2.2. Canada

10.2.3. Mexico

10.2.4. Costa Rica

10.3. South America

10.3.1. Brazil

10.3.2. Argentina

10.3.3. Chile

10.3.4. Columbia

10.3.5. Others

10.4. Europe

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Russia

10.4.7. Netherlands

10.4.8. Switzerland

10.4.9. Poland

10.4.10. Others

10.5. APAC

10.5.1. China

10.5.2. Japan

10.5.3. India

10.5.4. South Korea

10.5.5. Australia & New Zealand

10.5.6. Malaysia

10.5.7. Singapore

10.5.8. Others

10.6. Middle East & Africa

10.6.1. UAE

10.6.2. Saudi Arabia

10.6.3. Iran

10.6.4. Iraq

10.6.5. Qatar

10.6.6. South Africa

10.6.7. Algeria

10.6.8. Morocco

10.6.9. Nigeria

10.6.10. Egypt

10.6.11. Others

CHAPTER 11. GLOBAL CELL SIGNALING MARKET – COMPANY PROFILES

11.1. Beckman Coulter Inc.

11.2. Becton, Dickinson and Company

11.3. Bio-Rad Laboratories Inc.

11.4. Bio-Techne Corporation.

11.5. Cell Signaling Technology Inc.

11.6. The Merck Group

11.7. PerkinElmer Inc.

11.8. Promega Corporation.

11.9. Ge Healthcare.

11.10. Qiagen N.V.

11.11. Thermo Fisher Scientific Inc.

11.12. Luminex Corporation

11.13. Danaher Corporation.

11.14. Euro Clone S.p.A.

11.15. Irvine Scientific Sales Company, Inc.

CHAPTER 12. GLOBAL CELL SIGNALING MARKET – COMPETITIVE

LANDSCAPE

12.1. Market Share Analysis

12.2. Strategies adopted by top companies

12.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 13. MARKET INSIGHTS

13.1. Industry Experts Insights

13.2. Analysts Opinions

13.3. Investment Opportunities

CHAPTER 14. APPENDIX

14.1. List of Tables

14.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Envision Intelligence is the Main Supplier of Market Analysis Reviews, Customized Consulting Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time.Read More